CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −121 | $156.53 | $19K | 1,889 |
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −155 | $157.29 | $24K | 1,734 |
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −68 | $158.11 | $11K | 1,666 |
| 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −32 | $153.50 | $5K | 3,634 |
| 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −236 | $154.24 | $36K | 3,398 |
| 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −325 | $155.21 | $50K | 3,073 |
| 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −235 | $156.57 | $37K | 2,838 |
| 2026-05-04 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −172 | $157.49 | $27K | 2,666 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −52 | $153.89 | $8K | 4,614 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −288 | $154.38 | $44K | 4,326 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −346 | $155.48 | $54K | 3,980 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −82 | $156.24 | $13K | 3,898 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −106 | $157.45 | $17K | 3,792 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −65 | $158.35 | $10K | 3,727 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −38 | $159.08 | $6K | 3,689 |
| 2026-05-01 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −23 | $160.00 | $4K | 3,666 |
| 2026-04-30 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −42 | $155.68 | $7K | 5,624 |
| 2026-04-30 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −517 | $156.59 | $81K | 5,107 |
| 2026-04-30 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −340 | $157.37 | $54K | 4,767 |
| 2026-04-30 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −101 | $158.15 | $16K | 4,666 |
Page 5 of 10 · 186 trades